Political Checkpoint Webinar
Recording Now Available: Hear our latest healthcare perspective in the current political environment
An HMA Company
Future Frame Series
Join us on LinkedIn Live to discuss opportunities to grow and succeed in the evolving healthcare landscape
In the News
Expertise and Insights on Where the Industry is Heading
Explore Our Latest Thinking
6 Ways to Reduce Health Inequities during the COVID-19 Pandemic
Although the traumatic circumstances of the COVID-19 pandemic have exacerbated existing health inequities, it has also fueled an immediacy to address them. The CDC recently released two grant-funded initiatives for state and local health departments to mitigate COVID-19 related health disparities: National Initiative to Address COVID-19 Health Disparities Among Populations at High-Risk and Underserved, Including […]Read More >
Leavitt Partners Welcomes Brett Giroir, MD to the Firm
Salt Lake City, March 31, 2021 –Today, Leavitt Partners is pleased to announce that Brett Giroir, MD has joined the firm as a Distinguished Visiting Executive. Dr. Giroir will focus on addressing important healthcare topics such as bio-preparedness, value-based care arrangements, evolving issues with the COVID-19 pandemic, diagnostic testing and more. Brett Giroir, MD is […]Read More >
Newly Released Modeling Results Detail Timeline to Reaching COVID-19 Herd Immunity: Current Vaccination Projections and Trends to Monitor
Salt Lake City, March 16, 2021—Today, Leavitt Partners released “Using Modeling to Project Herd Immunity: When and how we will get back to normal,” a research paper outlining results from their current model to determine the expected timeline to reaching herd immunity from COVID-19. The research was conducted in response to growing interest in understanding […]Read More >
COVID-19: Guidance for Businesses and States
The coronavirus crisis poses an unprecedented challenge to our nation. Leavitt Partners’ experts have decades of experience working in the private and public health sectors as well as in the executive and legislative branches of the government. In response to this pandemic, Leavitt Partners has developed services to help clients address today’s urgency, while preparing for the “New Normal” around stabilization and recovery from this crisis.
Federal Insights & Advocacy
The Leavitt Partners Federal Insights and Advocacy team combines expertise in policy, regulatory consulting, advocacy, and reimbursement and is respected for integrity, expertise, and a record of success. With vast Congressional and agency experience combined with deep policy expertise, the team is uniquely positioned to advise and inform clients on the impact of federal health care issues and how to effectively engage with federal policymakers.
The United States health care system is undergoing a significant transformation, which will profoundly change the industry’s product and services transactions over the next decade. Leavitt Partners’ seasoned team of experts advises C-suite and other executives in making strategic decisions within the evolving heath care economy. Our intelligence provides our clients a better understanding of what the future likely holds.
Organizations with divergent interests often face common challenges and seek to capitalize on common opportunities. By utilizing consensus-based collaboration, organizations can address some of the most complex challenges in health care. Through Leavitt Partners’ deep health policy expertise and knowledge forming, convening, advising, and driving forward multi-sector alliances, we generate and advance policy and industry solutions not otherwise possible in today’s world.
CHART Model Support Services
Leavitt Partners offers expertise and services aligned with the newly announced Community Health Access and Rural Transformation (CHART) model track. We help identify and bring community leaders together to help identify the roles each will play in model participation. The information gathered during a community assessment will lay the foundation for the model to improve outcomes and better serve the health of the community and the viability of the rural health ecosystem. Leveraging insights from the community assessment, Leavitt Partners can support lead organizations in the development of their transformation plans.
New Entrants into Healthcare
The U.S. healthcare industry presents more than a $9 trillion market opportunity to investors. In 2020, the pandemic exposed several deficiencies in the current healthcare system as well as accelerated innovation around telehealth, insurance shifts, changes in consumer expectations, supply chain, the elevated need for and role of public health, and payment tied to value-based care. Leavitt Partners works with companies outside of the healthcare industry to assess the potential value of the company’s existing assets as they relate to healthcare opportunities and identify and recommend areas of opportunity for investment, growth, and strategic partnerships.
Pharmaceutical Manufacturer Services
As the healthcare industry continues the transition to value-based care, pharmaceutical manufacturers are looking to identify market opportunities that align to their strategic objectives around value-based contracting. The challenge lies in knowing which provider organizations are specifically impacted by value-based arrangements and how that impact is translating into changes in the delivery of care. Leavitt Partners has extensive experience helping pharmaceutical manufacturers engage with healthcare provider systems that are moving towards value and have more of their revenue tied to risk-based arrangements.